Joel Greenblatt’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$216K Buy
5,691
+933
+20% +$43K ﹤0.01% 1788
2026
Q2
$228K Buy
+4,758
New +$204K ﹤0.01% 1712
2026
Q1
– Sell
-3,987
Closed -$203K – 1831
2025
Q4
$203K Buy
+3,987
New +$204K ﹤0.01% 1652

Other funds holding NVO

Joel Greenblatt's NVO Position: Q3 2026 in Review

Joel Greenblatt increased its Novo Nordisk (NVO) stake by 20% in Q3 2026, buying an estimated $43K and bringing the position to 5,691 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1788.

Joel Greenblatt first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $228K in Q2 2026. 1,234 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Joel Greenblatt held 5,691 shares of Novo Nordisk worth $216K as of Q3 2026.
  • Joel Greenblatt bought 933 Novo Nordisk shares in Q3 2026, an estimated $43K.
  • Novo Nordisk made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1788 holding.
  • Joel Greenblatt first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Joel Greenblatt's Novo Nordisk position peaked at $228K in Q2 2026.
  • 1,234 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.